Intriguingly, antibody-mediated MARCO targeting promotes the M1-like polarization of TAMs and enhances immune checkpoint inhibitor (ICI) efficacy [32], indicating that knockdown of TMSB10 may enhance the efficacy of ICIs in GBM. Here, TMSB10 is linked to glioblastoma.